BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 99,700 shares, a growth of 129.7% from the March 31st total of 43,400 shares. Based on an average daily volume of 1,510,000 shares, the short-interest ratio is presently 0.1 days. Currently, 1.4% of the company’s stock are sold short.
BioNexus Gene Lab Stock Performance
NASDAQ:BGLC remained flat at $0.59 during mid-day trading on Friday. The company had a trading volume of 37,932 shares, compared to its average volume of 287,578. BioNexus Gene Lab has a fifty-two week low of $0.31 and a fifty-two week high of $17.88. The business has a fifty day simple moving average of $0.72 and a 200 day simple moving average of $0.61.
About BioNexus Gene Lab
Further Reading
- Five stocks we like better than BioNexus Gene Lab
- Market Cap Calculator: How to Calculate Market Cap
- MarketBeat Week in Review – 4/22 – 4/26
- The Significance of Brokerage Rankings in Stock Selection
- 3 Stocks Leading the U.S. Agriculture Comeback
- Basic Materials Stocks Investing
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.